Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure.
Level V
Where this comes from
- Record sourced from PubMed, PMID 20075952.
- Also identified by DOI 10.1038/ki.2009.455.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Anemia is common in chronic kidney disease (CKD). The CHOIR study found increased risk of a composite cardiovascular outcome when anemia was treated with epoetin-alfa to a target hemoglobin level of 13.5 as compared with 11.3 g/dl. Whether this increase applies to all patient subgroups equally is unclear. We discuss an analysis by Szczech and colleagues of the effects of the higher hemoglobin target in CKD patients with diabetes mellitus or congestive heart failure.
Medical subject headings
- Anemia
- Erythropoietin
- Heart Failure
- Kidney Diseases